-+ 0.00%
-+ 0.00%
-+ 0.00%

Rosenblatt Maintains Buy on Imax, Raises Price Target to $50

Benzinga·07/24/2026 12:57:12
Listen to the news
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $47 to $50.